Table 2.

Regression models for primary and secondary endpoints.

Variable	Odds ratio estimate	95% Confidence interval	p
GBS colonization at follow-up
Study group (verum vs. placebo)	0.500	0.158–1.582	0.24
Smoking status	1.081	0.189–6.169	0.93
Maternal age	1.049	0.936–1.175	0.41
Vaginal candidosis	0.375	0.022–6.384	0.50
Preterm birth
Study group (verum vs. placebo)	0.833	0.254–2.732	0.76
Smoking status	1.667	0.304–9.128	0.56
Parity	0.994	0.600–1.648	0.98
Maternal age	1.032	0.913–1.167	0.61
Birthweight
Study group (verum vs. placebo)	− 45.390	248.062–157.282	0.66
Smoking status	− 282.414	582.216–17.387	0.07
Parity	24.938	− 55.482–105.358	0.55
Maternal age	0.858	− 20.125–21.841	0.94
Gestational age at delivery
Study group (verum vs. placebo)	− 0.171	− 0.774–0.432	0.58
Smoking status	− 0.583	− 1.415–0.250	0.17
Parity	0.019	− 0.203–0.240	0.87
Maternal age	− 0.035	− 0.097–0.027	0.27
Mode of delivery
Study group (verum vs. placebo)	1.000	0.420–2.382	1.00
Smoking status	2.139	0.511–8.961	0.30
Parity	0.794	0.555–1.135	0.21
Maternal age	0.974	0.890–1.066	0.57